Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,532 | -9,986 | 17,888 | -56,693 | -24,620 |
| Depreciation Amortization | 10 | 6 | 4 | 4 | 8 |
| Accounts receivable | -2,637 | 372 | -1,298 | N/A | N/A |
| Accounts payable and accrued liabilities | 220 | 1,082 | -515 | 381 | 792 |
| Other Working Capital | 3,090 | 4,076 | -5,555 | 181 | 1,146 |
| Other Operating Activity | 31,273 | 3,338 | 3,790 | 36,757 | 15,877 |
| Operating Cash Flow | $-25,576 | $-1,112 | $14,314 | $-19,370 | $-6,797 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -100 | -1,475 |
| Net Acquisitions | 1,210 | N/A | N/A | N/A | 2,014 |
| Investing Cash Flow | $1,210 | $N/A | $N/A | $-100 | $539 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 646 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 23,347 |
| Common Stock Issued | 4,265 | 8,979 | 4,455 | 28,578 | 58 |
| Common Stock Repurchased | -79 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -669 | -1,619 | -2,285 |
| Financing Cash Flow | $4,186 | $8,979 | $3,786 | $27,605 | $21,120 |
| Beginning Cash Position | 50,501 | 42,634 | 24,534 | 16,399 | 1,537 |
| End Cash Position | 30,321 | 50,501 | 42,634 | 24,534 | 16,399 |
| Net Cash Flow | $-20,180 | $7,867 | $18,100 | $8,135 | $14,862 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,576 | -1,112 | 14,314 | -19,370 | -6,797 |
| Capital Expenditure | N/A | N/A | N/A | -100 | -1,475 |
| Free Cash Flow | -25,576 | -1,112 | 14,314 | -19,470 | -8,272 |